Filing Details
- Accession Number:
- 0001213900-25-045399
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-05-19 16:10:10
- Reporting Period:
- 2025-05-14
- Filing Date:
- 2025-05-19
- Accepted Time:
- 2025-05-19 16:10:10
- Original Submission Date:
- 2025-05-16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1359931 | Protara Therapeutics Inc. | TARA | Biological Products, (No Disgnostic Substances) (2836) | 204580525 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454983 | S Richard Levy | C/O Protara Therapeutics, Inc. 345 Park Avenue South, 3Rd Floor New York NY 10010 | No | No | No | No |
Transaction Summary
| Purchased: | 20,000 shares | Avg. Price: $3.19 | Total Value: $63,800.00 |
| Number of Shares After Transactions: | 51,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-14 | 20,000 | $3.19 | 51,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
